—  Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) reported earnings of $2.71 per share in the fourth-quarter 2019, vs. $2.60 per share expected. — Total revenue rose 23% to $1.38 billion, vs. … Continue reading Alexion Pharmaceuticals, Inc. (ALXN): Earnings Snapshot